Evaluation of PD-L1 expression in a large set of gastroenteropancreatic neuroendocrine tumours and correlation with clinicopathological data
-
Published:2022-11
Issue:
Volume:25
Page:101526
-
ISSN:1936-5233
-
Container-title:Translational Oncology
-
language:en
-
Short-container-title:Translational Oncology
Author:
Rösner Erik,
Kaemmerer DanielORCID,
Sänger JörgORCID,
Lupp AmelieORCID
Subject
Cancer Research,Oncology
Reference58 articles.
1. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumours in 35,825 cases in the United States;Yao;J. Clin. Oncol.,2008
2. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes;Hallet;Cancer,2015
3. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;Dasari;JAMA Oncol.,2017
4. Gastroenteropancreatic neuroendocrine tumors;Cives;CA Cancer J. Clin.,2018
5. Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumours in the United States;Xu;JAMA Netw. Open,2021
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献